ampicillin has been researched along with resiquimod in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Annunziato, F; Brugnolo, F; Campi, P; Cosmi, L; Liotta, F; Maggi, E; Manuelli, C; Parronchi, P; Romagnani, S; Sampognaro, S | 1 |
Abt, MC; Artis, D; Becattini, S; Buffie, CG; Carter, RA; Keith, JW; Leiner, I; Osborne, LC; Pamer, EG; SuĊĦac, B | 1 |
2 other study(ies) available for ampicillin and resiquimod
Article | Year |
---|---|
The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-gamma-producing cells.
Topics: Adjuvants, Immunologic; Adult; Allergens; Ampicillin; Animals; Antigens, Dermatophagoides; Arthropod Proteins; Cell Line; Cysteine Endopeptidases; Cytokines; Drug Hypersensitivity; Humans; Hypersensitivity, Immediate; Imidazoles; In Vitro Techniques; Interferon-gamma; Models, Immunological; T-Lymphocyte Subsets; Th1 Cells; Th2 Cells | 2003 |
TLR-7 activation enhances IL-22-mediated colonization resistance against vancomycin-resistant enterococcus.
Topics: Ampicillin; Animals; Caliciviridae Infections; CD11c Antigen; Colony Count, Microbial; Dendritic Cells; Drug Resistance, Bacterial; Enterococcus; Gastroenteritis; Imidazoles; Interferon Type I; Interleukin-1; Interleukin-22; Interleukin-23; Interleukins; Ligands; Mice, Inbred C57BL; Norovirus; Pancreatitis-Associated Proteins; Proteins; Signal Transduction; Toll-Like Receptor 7; Vancomycin | 2016 |